Develop Car-T For Hematological Malignancies
21/03/2018 12:18
March 21 (Reuters) - Helix Biopharma Corp HBP.TO :
* HELIX BIOPHARMA CORP. SIGNS COLLABORATION AGREEMENT WITH
PROMAB
BIOTECHNOLOGIES TO CO-DEVELOP CAR-T FOR HEMATOLOGICAL
MALIGNANCIES
Source text for Eikon: ID:nGNX88Glm8
Further company coverage: HBP.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Helix Biopharma
See all newsBrief: Helix Biopharma Reports Q3 Loss Per Share C$0.02
Brief: Helix Biopharma Intends To File Interim Consolidated Financial Statements By July 30
Brief: Helix Biopharma To Divest Remaining Ownership Of Polish Subsidiary
Brief: Helix Biopharma Says Expects To File Interim Disclosure Documents By July 30, 2020
Brief: Helix Biopharma Says L-Dos47 Phase I Lung Cancer Trial Data To Be Released At Asco 2020